WHO Recommendations: Deworming in Pregnant Women

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
deworming women thmbnl
Detail Image
deworming women mob det img
Book Detail
Publication Date
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Soil-transmitted helminth infections—caused by worms such as roundworms, whipworms, and hookworms—are common among people living in poverty and can lead to anemia, intestinal issues, and poor nutrient absorption.

The WHO advises preventive chemotherapy with a single dose of albendazole (400 mg) or mebendazole (500 mg) for pregnant women after the first trimester in areas where worm infections affect 20% or more and anemia prevalence exceeds 40%.

This intervention, part of WHO’s antenatal care guidelines, helps reduce worm burden and improve maternal health, alongside long-term measures like better sanitation and hygiene.

Published Date